Bcl-2 proteins in diabetes: Mitochondrial pathways of β-cell death and dysfunction

Trends in Cell Biology

Volumn 21, Issue 7, 2011, Pages 424-431

  Gurzov, Esteban N ^a   Eizirik, Decio L ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; CELL FUNCTION; DISEASE MODEL; ENDOPLASMIC RETICULUM STRESS; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOTOXICITY; MITOCHONDRIAL PERMEABILITY; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW;

ANIMALS; CELL DEATH; DIABETES MELLITUS; HUMANS; INSULIN-SECRETING CELLS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 79959618962     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2011.03.001     Document Type: Review

References (82)

1. (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197.
2. Cnop M., et al. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005, 54:S97-S107.
3. Passa P. Diabetes trends in Europe. Diab. Metab. Res. Rev. 2002, 18:S3-8.
4. Roivainen M., Klingel K. Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 2009, 52:995-996.
5. Kahn S.E., et al. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009, 52:1003-1012.
6. Rhodes C.J. Type 2 diabetes-a matter of β-cell life and death?. Science 2005, 307:380-384.
7. Eizirik D.L., et al. The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 2009, 5:219-226.
8. Eizirik D.L., Mandrup-Poulsen T. A choice of death-the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 2001, 44:2115-2133.
9. Thomas H.E., et al. Beta cell apoptosis in diabetes. Apoptosis 2009, 14:1389-1404.
10. Lehuen A., et al. Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 2010, 10:501-513.
11. Concannon P., et al. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009, 58:1018-1022.
12. Moore F., et al. PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ-induced pancreatic β-cell apoptosis. Diabetes 2009, 58:1283-1291.
13. Colli M.L., et al. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA. Hum. Mol. Genet. 2010, 19:135-146.
14. Butler A.E., et al. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
15. Florez J.C. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?. Diabetologia 2008, 51:1100-1110.
16. Cardozo A.K., et al. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem. 2001, 276:48879-48886.
17. Moore F., et al. STAT1 is a master regulator of pancreatic beta cells apoptosis and islet inflammation. J. Biol. Chem. 2011, 286:929-941.
18. Eizirik D.L., et al. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 2008, 29:42-61.
19. Grunnet L.G., et al. Proinflammatory cytokines activate the intrinsic apoptotic pathway in β-cells. Diabetes 2009, 58:1807-1815.
20. Gurzov E.N., et al. p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J. Biol. Chem. 2010, 285:19910-19920.
21. Cunha D.A., et al. Glucagon-like peptide-1 agonists protect pancreatic β-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 2009, 58:2851-2862.
22. Cardozo A.K., et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 2005, 54:452-461.
23. Cunha D.A., et al. Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J. Cell Sci. 2008, 121:2308-2318.
24. Laybutt D.R., et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007, 50:752-763.
25. Oyadomari S., et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 2002, 109:525-532.
26. Song B., et al. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J. Clin. Invest. 2008, 118:3378-3389.
27. Marchetti P., et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 2007, 50:2486-2494.
28. Akerfeldt M.C., et al. Cytokine-induced β-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 2008, 57:3034-3044.
29. Oyadomari S., et al. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10845-10850.
30. Gross A., et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 1998, 17:3878-3885.
31. Kim H., et al. Stepwise activation of BAX and BAK by tBID BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell 2009, 36:487-499.
32. Tait S.W., Green D.R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 2010, 11:621-632.
33. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
34. Arndt T., et al. Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes. Diabetologia 2009, 52:1381-1390.
35. O'Sullivan B.J., et al. IL-1β breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 2006, 176:7278-7287.
36. Kim S., et al. Essential role for signal transducer and activator of transcription-1 in pancreatic β-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Diabetes 2007, 56:2561-2568.
37. Allagnat F., et al. Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to β-cell apoptosis. Cell Death Differ. 2011, 18:328-337.
38. Delaney C.A., et al. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 1997, 138:2610-2614.
39. Kim H.S., et al. IFN-γ sensitizes MIN6N8 insulinoma cells to TNF-α-induced apoptosis by inhibiting NF-κB-mediated XIAP upregulation. Biochem. Biophys. Res. Commun. 2005, 336:847-853.
40. Gurzov E.N., et al. Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ. 2009, 16:1539-1550.
41. Sarkar S.A., et al. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor κ-B (NF-κB) signalling in human islets and in a mouse beta cell line. Diabetologia 2009, 52:1092-1101.
42. Gurzov E.N., et al. JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells. PLoS ONE 2008, 3:e3030.
43. Inohara N., et al. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J. 1997, 16:1686-1694.
44. Imaizumi K., et al. Molecular cloning of a novel polypeptide DP5, induced during programmed neuronal death. J. Biol. Chem. 1997, 272:18842-18848.
45. Imaizumi K., et al. Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death. J. Neurosci. 2004, 24:3721-3725.
46. Gao M., et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004, 306:271-275.
47. Inoshita S., et al. Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J. Biol. Chem. 2002, 277:43730-43734.
48. Kim H., et al. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 2006, 8:1348-1358.
49. Carrington E.M., et al. Islet β-cells deficient in Bcl-xL develop but are abnormally sensitive to apoptotic stimuli. Diabetes 2009, 58:2316-2323.
50. Ortis F., et al. Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic β-cells. Diabetologia 2008, 51:1213-1225.
51. Puthalakath H., et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 2007, 129:1337-1349.
52. White C., et al. The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat. Cell Biol. 2005, 7:1021-1028.
53. Thomas H.E., et al. The role of perforin and granzymes in diabetes. Cell Death Differ. 2010, 17:577-585.
54. Sutton V.R., et al. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J. Exp. Med. 2000, 192:1403-1414.
55. Estella E., et al. Granzyme B-mediated death of pancreatic β-cells requires the proapoptotic BH3-only molecule bid. Diabetes 2006, 55:2212-2219.
56. Chervonsky A.V., et al. The role of Fas in autoimmune diabetes. Cell 1997, 89:17-24.
57. McKenzie M.D., et al. Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic β-cells. Diabetes 2008, 57:1284-1292.
58. Federici M., et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 2001, 50:1290-1301.
59. McKenzie M.D., et al. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 2009, 59:644-652.
60. Danial N.N. BAD: undertaker by night, candyman by day. Oncogene 2008, 27:S53-70.
61. Hetz C., Glimcher L. The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology. Trends Cell Biol. 2008, 18:38-44.
62. Szegezdi E., et al. Bcl-2 family on guard at the ER. Am. J. Physiol. Cell Physiol. 2009, 296:C941-953.
63. Wang X., et al. Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell Death Differ. 2011, 18:38-47.
64. Danial N.N., et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat. Med. 2008, 14:144-153.
65. Zhou Y.P., et al. Overexpression of Bcl-x(L) in β-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E340-351.
66. Johnson J.D., et al. Increased islet apoptosis in Pdx1+/- mice. J. Clin. Invest. 2003, 111:1147-1160.
67. Holohan C., et al. Cytokine-induced β-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. J. Cell. Mol. Med. 2008, 12:591-606.
68. Liu Y., et al. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic β-cells from apoptosis. Hum. Gene. Ther. 1996, 7:1719-1726.
69. Chonghaile T.N., Letai A. Mimicking the BH3 domain to kill cancer cells. Oncogene 2008, 27(Suppl. 1):S149-157.
70. Vogler M., et al. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ. 2009, 16:360-367.
71. Chipuk J.E., et al. The BCL-2 family reunion. Mol. Cell 2010, 37:299-310.
72. Brunelle J.K., Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 2009, 122:437-441.
73. Kaneko M., et al. Activation signal of nuclear factor-κB in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2. Biol. Pharm. Bull. 2003, 26:931-935.
74. Hu P., et al. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-κB activation and down-regulation of TRAF2 expression. Mol. Cell. Biol. 2006, 26:3071-3084.
75. Wang P., et al. PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis. Cell Death Differ. 2009, 16:1192-1202.
76. Jiang L., et al. Plasma membrane Ca2+-ATPase overexpression depletes both mitochondrial and endoplasmic reticulum Ca2+ stores and triggers apoptosis in insulin-secreting BRIN-BD11 cells. J. Biol. Chem. 2010, 285:30634-30643.
77. Lim J.H., et al. Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. Cell Signal. 2009, 21:169-177.
78. Deniaud A., et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 2008, 27:285-299.
79. Oakes S.A., et al. The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins. Curr. Mol. Med. 2006, 6:99-109.
80. Lam M., et al. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:6569-6573.
81. Wei M.C., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
82. Zhang D., Armstrong J.S. Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis. Cell Death Differ. 2007, 14:703-715.